News | Medilink

Featured

Important announcement: UK pavilions commitment to Medica 2020

With the unprecedented circumstances caused by COVID-19, there have been a number of questions whether Medica, the largest medical technology exhibition in the world, will go ahead this year. Messe Düsseldorf, the organisers of Medica, are still planning for the show to take place from 16th to 19th November, with Medilink UK and Gambica being…

Medilink North of England – message to our members

We are all facing unprecedented challenges with the Covid-19 crisis. Our UK Lifescience industry has always been on the front line when it comes to responding to the changing needs of healthcare delivery but never before has this been more visible than in the current Covid-19 crisis. We have member companies working around the clock, producing…

ADL Smartcare joins collaboration to help elderly people stay independent

ADL Smartcare, experts in shaping the future of care with evidence-based data, research, knowledge and intelligence on age-related decline, and Medilink member, has announced a collaboration which will help address issues experienced by elderly people. Project Maslow brings together ADL Smartcare, E.ON, the National Innovation Centre for Ageing, Newcastle University and Invisible Creations® to help…

Important announcement about Arab Health – postponement of 2021 event

After careful consideration from the organisers, authorities and key stakeholders, it has been decided that Arab Health 2021 will be postponed from 1 - 4 February 2021 with the new confirmed dates of 21 – 24 June 2021. The event will take place, as always, at the Dubai World Trade Centre, United Arab Emirates. All…

Abingdon Health receives CE mark for its COVID-19 rapid antibody test

Abingdon Health, a York-based diagnostics company leading the UK-Rapid Test Consortium (UK-RTC), and Medilink member, has received a CE mark for its COVID-19 rapid antibody test, which means that it is now approved for professional use in the UK and EU. The rapid test for detection of lgG antibodies to the SARS-CoV-2 virus will be…

How to overcome challenges in demonstrating the value of drugs for rare diseases? An insight by BresMed

With challenges surrounding clinical trials in rare diseases, such as small sample sizes and heterogenous populations, it is difficult to achieve the comparative effectiveness and safety of a novel product. In its new paper, BresMed, a company specialising in health economics and Medilink member, explores these challenges in more depth and proposes a new framework…